Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas

Japanese Journal of Cancer Research

Volumn 92, Issue 10, 2001, Pages 1062-1073

  Mikami, Shuji ^a,f   Ohashi, Kenichi ^b   Usui, Yutaka ^c   Nemoto, Tetsuo ^a   Katsube, Ken Ichi ^a   Yanagishita, Masaki ^a   Nakajima, Motowo ^d   Nakamura, Kyouichi ^e   Koike, Morio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

^d NOVARTIS PHARMA K K   (Japan)

^e YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^f KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Esophageal squamous cell carcinoma (ESCC); Heparan sulfate proteoglycan (HSPG); Heparanase; Syndecan 1

Indexed keywords

BIOLOGICAL FACTOR; CORE PROTEIN; GLYCOSAMINOGLYCAN POLYSULFATE; GROWTH FACTOR; HEPARANASE; MESSENGER RNA; PARAFFIN; PROTEOHEPARAN SULFATE; SYNDECAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR DIFFERENTIATION; VEIN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SYNDECAN-1; SYNDECANS; TUMOR CELLS, CULTURED;

EID: 0034764665     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01061.x     Document Type: Article

References (45)

1. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma
2. Proliferative activity and p53 protein accumulation correlate with early invasive trend, and apoptosis correlates with differentiation grade in oesophageal squamous cell carcinomas
3. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas
4. Functions of cell surface heparan sulfate proteoglycans
5. Cell surface heparan sulfate proteoglycans
6. Syndecans: Multifunctional cell-surface co-receptors
7. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study
8. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation
9. Syndecan in carcinomas produced from transformed epithelial cells in nude mice
10. Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify
11. Syndecan-1 expression has prognostic significance in head and neck carcinoma
12. Syndecan-1: A new prognostic marker in laryngeal cancer
13. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma
14. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck
15. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix
16. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential
17. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma
18. Heparan sulfate degradation: Relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines
19. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase
20. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relationship to tumor cell metastasis
21. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma: Evidence for its role in colonic tumorigenesis
22. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
23. Cloning and functional expression of a human heparanase gene
24. Human heparanase. Purification, characterization, cloning, and expression
25. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
26. In collaboration with pathologists in 8 countries
27. Developmental changes in heparan sulfate expression: In situ detection with mAbs
28. A syngeneic monoclonal antibody to murine meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): Cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1
29. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase
30. Quantification of hepatitis C virus by Taq-Man PCR: Comparison with HCV Amplicor Monitor assay
31. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
32. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes
33. The coordinated regulation of heparan sulfate, syndecans and cell behavior
34. Integrins
35. Cadherin cell adhesion receptors as a morphogenetic regulator
36. The role of proteoglycans in cell adhesion, migration and proliferation
37. Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells
38. Expression of syndecan-1 inhibits cell invasion into type I collagen
39. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells
40. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan
41. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney
42. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases
43. Inhibition of tumor metastasis by heparanase inhibiting species of heparin
44. Expression of heparanase in oral cancer cell lines and oral cancer tissues